Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

Betts CA, McClorey G, Healicon R, Hammond SM, Manzano R, Muses S, Ball V, Godfrey C, Merritt TM, van Westering T, O'Donovan L, Wells KE, Gait MJ, Wells DJ, Tyler D, Wood MJ.

Hum Mol Genet. 2019 Feb 1;28(3):396-406. doi: 10.1093/hmg/ddy346.

2.

Can we trust studies using audit software?

Wakeham C, Healicon R, Lemar M.

Br J Gen Pract. 2016 Jan;66(642):15. doi: 10.3399/bjgp16X683125. No abstract available.

3.

The use of anticoagulants in the management of atrial fibrillation among general practices in England.

Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, Tyndall K, Gale CP.

Heart. 2013 Aug;99(16):1166-72. doi: 10.1136/heartjnl-2012-303472. Epub 2013 Feb 7.

4.

p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids.

Tiniakos DG, Healicon RM, Hair T, Wadehra V, Horne CH, Angus B.

Acta Cytol. 1995 Mar-Apr;39(2):171-6.

PMID:
7887063
5.

Meckel syndrome: what are the minimum diagnostic criteria?

Wright C, Healicon R, English C, Burn J.

J Med Genet. 1994 Jun;31(6):482-5.

6.

Isolation and characterization of an oestrogen-responsive breast-cancer cell line, EFF-3.

Healicon RM, Westley BR, May FE.

Int J Cancer. 1993 Feb 1;53(3):388-94.

PMID:
8428792
8.
9.

Supplemental Content

Loading ...
Support Center